期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 106, 期 2, 页码 350-359出版社
WILEY
DOI: 10.1002/cpt.1483
关键词
-
资金
- Canadian Institutes of Health Research (CIHR) Postdoctoral Fellowship
- CIHR SEARCH/PREVENT DSEN Team Grant
Cisplatin is a highly effective chemotherapeutic. Unfortunately, its use is limited by cisplatin-induced ototoxicity (CIO). Substantial research has been performed to uncover the genetic variants associated with CIO; however, there has been a lack of consistency in the results that have been reported. This paper aims to provide an overview of the current state of CIO genomics research, delving into the shortcomings of past research, and providing recommendations for future avenues of study.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据